Table 3.
Multiple logistic regression for the prevalence of diseases by tobacco use type, South Korea, 2018–2020
COPD | Asthma | Allergic rhinitis | Sinusitis | Atopic dermatitis | |
---|---|---|---|---|---|
AOR (95% CI) | AOR (95% CI) | AOR (95% CI) | AOR (95% CI) | AOR (95% CI) | |
Model 1 | |||||
No tobacco use (Ref.) | 1 | 1 | 1 | 1 | 1 |
Past tobacco use | 2.37 (1.02–5.51) | 1.73 (1.26–2.38) | 1.33 (1.13–1.57) | 1.05 (0.85–1.29) | 0.98 (0.69–1.38) |
Current exclusive CC use | 1.42 (0.50–4.00) | 1.57 (1.08–2.26) | 0.92 (0.78–1.09) | 0.89 (0.70–1.13) | 0.97 (0.72–1.32) |
Current exclusive HTPs use | NA | 0.59 (0.15–2.33) | 1.60 (1.06–2.42) | 0.87 (0.48–1.58) | 1.21 (0.57–2.56) |
Current dual use | NA | 1.54 (0.82–2.90) | 1.01 (0.74–1.37) | 1.11 (0.73–1.68) | 1.10 (0.65–1.85) |
Model 2 | |||||
No tobacco use | 0.70 (0.25–1.98) | 0.64 (0.44–0.92) | 1.08 (0.91– 1.29) | 1.12 (0.89–1.42) | 1.03 (0.76–1.40) |
Past tobacco use | 1.67 (0.56–4.95) | 1.10 (0.79–1.55) | 1.45 (1.20–1.75) | 1.18 (0.93–1.49) | 1.00 (0.71–1.42) |
Current exclusive CC use (Ref.) | 1 | 1 | 1 | 1 | 1 |
Current exclusive HTPs use | NA | 0.38 (0.10–1.50) | 1.74 (1.14–2.66) | 0.97 (0.53–1.80) | 1.24 (0.59–2.64) |
Current dual use | NA | 0.98 (0.52–1.86) | 1.09 (0.80–1.50) | 1.25 (0.81–1.92) | 1.13 (0.69–1.87) |
COPD: chronic obstructive pulmonary disease. CC: combustible cigarette. HTPs: heated tobacco products. AOR: adjusted odds ratio; adjusted for age, sex, education level, average monthly household income, monthly alcohol consumption, physical activity, obesity status, and comorbidities.